Clinical Trials Directory

Trials / Completed

CompletedNCT07479875

Caffeine Supplementation and Strength Endurance in Brazilian Jiu-jitsu Athletes

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
15 (actual)
Sponsor
Federal University of Minas Gerais · Academic / Other
Sex
Male
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

This study investigated the acute effects of ingesting 400 mg of caffeine administered 30 minutes before Brazilian jiu-jitsu-specific strength endurance tests. Experienced athletes completed two conditions, placebo and caffeine, in a randomized, double-blind, crossover clinical trial. Performance was assessed using the dynamic component of the kimono grip strength test (maximum number of repetitions, MNR) and the isometric component (maximum static lift, MSL), both performed with a gi grip. Rating of perceived exertion, adverse effects, and blinding effectiveness were also evaluated.

Detailed description

Caffeine is a widely used ergogenic aid in combat sports due to its effects on alertness, strength, and muscular endurance. This study evaluated whether an absolute dose of 400 mg of caffeine, ingested 30 minutes before testing, improved performance in Brazilian jiu-jitsu-specific strength endurance tests performed with a gi grip. Fifteen experienced athletes completed two experimental sessions separated by at least seven days in a randomized, double-blind, crossover design. In each session, participants performed three maximal sets of the dynamic component of the kimono grip strength test (maximum number of repetitions, MNR) and three trials of the isometric component (maximum static lift, MSL). Dietary intake was controlled during the 24 hours preceding each session, and athletes were instructed to avoid stimulant substances. Adverse effects were monitored for 24 hours following each session, and blinding effectiveness was assessed using the Bang blinding index. The study also examined interindividual variability in response to caffeine supplementation.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTCaffeineCapsule containing 400 mg of anhydrous caffeine ingested 30 minutes before performance testing.
OTHERPlaceboCapsule containing 400 mg of cornstarch used as placebo, ingested 30 minutes before performance testing.

Timeline

Start date
2025-12-12
Primary completion
2026-01-15
Completion
2026-01-15
First posted
2026-03-18
Last updated
2026-03-18

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT07479875. Inclusion in this directory is not an endorsement.